Drugs Remdesivir, Hydroxychloroquine, Lopinavir/Ritonavir and Favipiravir, currently being used for COVID-19 patients, have come under the Health Ministry’s scanner. Senior officials have confirmed that with both national and international information and trial results coming in for these drugs, “constant monitoring and review for use are essential.”
Also read | COVID-19 vaccine: Completion of trials could take at least 6 to 9 months, says Soumya Swaminathan
“We are waiting and watching,” said a senior Health Ministry official.
Top on the chart for review is drug Remdesivir which is presently allowed for restricted use in moderate COVID-19 cases.
Rise in alkaline levels
“Remdesivir is showing reports of liver damage in patients from across India. There are multiple evidence that patients who have been given the drug showed rise in levels of alkaline ph